GB1054698A - - Google Patents
Info
- Publication number
- GB1054698A GB1054698A GB1054698DA GB1054698A GB 1054698 A GB1054698 A GB 1054698A GB 1054698D A GB1054698D A GB 1054698DA GB 1054698 A GB1054698 A GB 1054698A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- acid
- ascorbic acid
- salt
- cackets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 abstract 2
- 239000011668 ascorbic acid Substances 0.000 abstract 2
- 229960005070 ascorbic acid Drugs 0.000 abstract 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- 239000004260 Potassium ascorbate Substances 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229960004203 carnitine Drugs 0.000 abstract 1
- 229960002104 cyanocobalamin Drugs 0.000 abstract 1
- 235000000639 cyanocobalamin Nutrition 0.000 abstract 1
- 239000011666 cyanocobalamin Substances 0.000 abstract 1
- 229960002061 ergocalciferol Drugs 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 abstract 1
- 229960001252 methamphetamine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 235000010603 pastilles Nutrition 0.000 abstract 1
- 235000019275 potassium ascorbate Nutrition 0.000 abstract 1
- 229940017794 potassium ascorbate Drugs 0.000 abstract 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 abstract 1
- 235000008160 pyridoxine Nutrition 0.000 abstract 1
- 239000011677 pyridoxine Substances 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 235000019192 riboflavin Nutrition 0.000 abstract 1
- 239000002151 riboflavin Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 235000019157 thiamine Nutrition 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 239000011721 thiamine Substances 0.000 abstract 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 abstract 1
- 235000001892 vitamin D2 Nutrition 0.000 abstract 1
- 239000011653 vitamin D2 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4933064 | 1964-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1054698A true GB1054698A (enrdf_load_stackoverflow) |
Family
ID=10451983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1054698D Active GB1054698A (enrdf_load_stackoverflow) | 1964-12-04 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE673254A (enrdf_load_stackoverflow) |
| FR (1) | FR5013M (enrdf_load_stackoverflow) |
| GB (1) | GB1054698A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4414212A (en) * | 1981-12-10 | 1983-11-08 | Graham J. Naylor | Method of treatment of pre-menstrual syndrome |
| US4704352A (en) * | 1985-06-25 | 1987-11-03 | Baxter Travenol Laboratories, Inc. | L-ascorbate-2-phosphate salts in blood cell storage |
| WO1999053921A1 (en) * | 1998-04-17 | 1999-10-28 | Sigma-Tau Healthscience S.P.A. | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph |
| WO2015176848A1 (en) * | 2014-05-21 | 2015-11-26 | Bauer K H | Self-drying dosage form with controllable drying time and drying rate |
-
0
- GB GB1054698D patent/GB1054698A/en active Active
-
1965
- 1965-12-03 BE BE673254D patent/BE673254A/xx unknown
- 1965-12-03 FR FR40816A patent/FR5013M/fr not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4414212A (en) * | 1981-12-10 | 1983-11-08 | Graham J. Naylor | Method of treatment of pre-menstrual syndrome |
| US4704352A (en) * | 1985-06-25 | 1987-11-03 | Baxter Travenol Laboratories, Inc. | L-ascorbate-2-phosphate salts in blood cell storage |
| WO1999053921A1 (en) * | 1998-04-17 | 1999-10-28 | Sigma-Tau Healthscience S.P.A. | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph |
| AU750645B2 (en) * | 1998-04-17 | 2002-07-25 | Sigma-Tau Healthscience S.P.A. | Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
| WO2015176848A1 (en) * | 2014-05-21 | 2015-11-26 | Bauer K H | Self-drying dosage form with controllable drying time and drying rate |
Also Published As
| Publication number | Publication date |
|---|---|
| BE673254A (enrdf_load_stackoverflow) | 1966-06-03 |
| FR5013M (enrdf_load_stackoverflow) | 1967-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL36018A0 (en) | New 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them | |
| GB1204580A (en) | Pharmaceutical dosage forms | |
| HU172709B (hu) | Sposob poluchenija proizvodnykh difenil efirov, i gerbicidnykh kompozicijj soderzhahhikh ikh aktivnymiagentami | |
| IL35729A0 (en) | 2-(5-nitro-2-furyl)-thieno (3.2-d) pyrimidines,their preparation and pharmaceutical compositions containing them | |
| HU170778B (hu) | Fungicidnye kompozicii i sposob poluchenija proizvodnykh l-propil-imidazola i soli, to est' soedinenijj primenimykh aktivnymi agentami | |
| ES479423A1 (es) | Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina. | |
| NO145380C (no) | Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskaps-avbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon | |
| GB1054698A (enrdf_load_stackoverflow) | ||
| GB1247801A (en) | Pharmaceutical compositions | |
| IL47937A0 (en) | Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof | |
| GB1356097A (en) | Mineral salt preparation | |
| GB1191246A (en) | Vitamin-containing Preparations | |
| DK123141B (da) | Fremgangsmåde til stabilisering af et til oral indgift egnet farmaceutisk præparat, indeholdende en basisk dihydrodibenzazepin. | |
| GB1344558A (en) | Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor | |
| CA936533A (en) | 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation | |
| NL142589B (nl) | Werkwijze voor het op in de farmacie gebruikelijke wijze bereiden van stabiele waterige oplossingen van een zout van een 21-fosfaat van een 21-hydroxysteroide, geschikt voor parenterale toediening. | |
| GB1289096A (enrdf_load_stackoverflow) | ||
| GB1187946A (en) | Dimethylbiguanide Derivative | |
| ES264510A1 (es) | Metodo para la preparaciën de preparados de hierro de elevado poder de absorciën | |
| GB1263839A (en) | A novel aminoethanesulfonic acid | |
| GB1153324A (en) | Sustained Release Tablets | |
| FI51900C (fi) | Menetelmä tablettien valmistamiseksi, josta aktiivinen aine liukenee h idastetusti. | |
| GB1336609A (en) | Antismoking preparation | |
| CA960655A (en) | N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| IL30488A0 (en) | Pharmaceutical compositions comprising as an active ingredient p-benzoylphenylacetic acid,o-benzoylphenylacetic acid or salts thereof |